Financial Year |
March 31 2023 |
Monetary Funds |
232,325,480.70 |
Held-for-trading Financial Assets |
267,111,686.22 |
Notes Receivable |
152,000.00 |
Accounts Receivable |
209,534,336.03 |
Advances to Suppliers |
6,109,363.14 |
Other Receivables |
2,540,194.03 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
147,070,462.26 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
1,809,352.90 |
Total Current Assets |
930,953,752.02 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
248,821,152.94 |
Under-construction Projects |
60,096,094.57 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
52,076,690.39 |
R&D expenses |
-- |
Goodwill |
103,983,861.22 |
Long-Term Deferred and Prepaid Expenses |
5,351.93 |
Deferred Income Tax Assets |
4,207,218.81 |
Other Non-Current Assets |
7,908,721.50 |
Sub-Total of Non-Current Assets |
477,915,658.98 |
Total Assets |
1,408,869,411.00 |
Short-Term Loans |
146,001,111.11 |
Trading Financial liabilities |
-- |
Notes Payable |
62,948,393.78 |
Accounts Payable |
135,723,842.11 |
Accounts Received In Advance |
114,864.99 |
Employee Compensation Payable |
8,035,454.75 |
Taxes Payable |
6,989,494.86 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
4,575,439.17 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
307,694.22 |
Other Current Liabilities |
75,430.87 |
Sub-Total of Current Liabilities |
365,155,715.82 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
9,261,058.36 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
10,053,667.15 |
Total Liabilities |
375,209,382.97 |
Paid-In Capital(Or Share Stock) |
178,516,800.00 |
Capital Surplus |
373,034,101.55 |
Surplus Reserve |
45,057,281.77 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
436,189,799.92 |
Minority Stockholder's Interest |
894,520.21 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,032,765,507.82 |
Owner's Equity(Stockholder's Equity) |
1,033,660,028.03 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,408,869,411.00 |